Rheumatology (Oxford, England)
Cure8 research brief
Arthritis in inflammatory bowel disease.
Complications
Immune Pathways
Biomarkers
Joint Pain
Joint Inflammation
Clinical study
Adult patients
Clinicians
Why This Matters
Joint inflammation is a common and impactful extraintestinal issue in IBD; recognizing and treating it appropriately affects symptoms, function, and quality of life.
Who Should Pay Attention
Adult patients with Crohn's disease or ulcerative colitis (especially those with new or chronic joint pain), gastroenterologists, rheumatologists, and clinicians involved in multidisciplinary IBD care; researchers studying immune mechanisms or biomarkers.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
The article is a narrative review focusing on epidemiology, pathophysiology, clinical features, diagnostic strategies, and management of IBD-associated axial and peripheral spondyloarthritis.
It highlights shared mechanisms (genetics, immune pathways, intestinal barrier issues, and lymphocyte trafficking), limitations of serologic biomarkers, variable timing between gut and joint disease, and the need to choose therapies that address both bowel and joint inflammation.
Care coordination and multidisciplinary clinics are emphasized as improving diagnosis, outcomes, and patient satisfaction. The review notes that newer biologics and targeted therapies differ in effectiveness for intestinal versus articular disease and require careful selection.
Keep In Mind
This item is a narrative review (abstract-level content provided). It summarizes existing evidence rather than reporting new trial data. Diagnostic biomarkers and treatment choices can be complex; individualized care with gastroenterology and rheumatology input is often required.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationRheumatology (Oxford, England)
AuthorsElena Bartoloni, Flavio Caprioli, Alessandro Armuzzi +5 more
InstitutionRheumatology Unit, Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedAug 13, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Arthralgia, EIMs Linked to Risk for IBD-Related Arthritis in Crohn Disease
Arthralgia and other extraintestinal symptoms may signal higher risk of developing peripheral arthritis in people with Crohn disease. Recognizing early joint pain could prompt closer monitoring or earlier rheumatology...
Possible biomarker identified for Crohn’s disease with arthritis type
This study points to a possible microbiome biomarker (M. gnavus) tied to joint inflammation in people with Crohn’s disease, which could help explain why some patients develop arthritis and might eventually inform...
Serum Leptin, Ghrelin, and IGF-1 Levels and Their Association with Bone Mineral Density in Patients with Ulcerative Colitis
People with UC have higher rates of low bone density, which raises fracture risk. This study links altered hormones (leptin, ghrelin, IGF‑1) and inflammation to lower BMD in UC, suggesting metabolic pathways that could...